Technical Update - GN Store Nord, Demant, Rockwool & Chemometic Technical Update - GN Store Nord, Demant, Rockwool & Chemometic Technical Update - GN Store Nord, Demant, Rockwool & Chemometic

Technical Update - GN Store Nord, Demant, Rockwool & Chemometic

Equities 4 minutes to read
KCL
Kim Cramer Larsson

Technical Analyst, Saxo Bank

Summary:  GN Store Nord bounce after being beaten
Demant collapse after bullish break out
Rockwool could be range bound for a long time
Chemometic bubble implosion


Today's Market Quick Take from the Saxo Strategy Team

GN Store Nord
had broken above resistance at 190.75 yesterday – maybe in anticipation of a positive earnings announcement pre-market today. That didn’t happen and GN Store Nord opened 20% lower this morning but have bounced back currently trading above the lower rising trend line.
If closing above 159.60 the uptrend is still intact. A close below and GN is likely to be hit by a sell-off down to previous lows. A close below 144.30 is likely confirm and fuel the down trend
For GN to resume uptrend a close of the gap created this morning would be minimum requirement.


Medium-term the uptrend is in jeopardy if GN closes below 144.30. Weekly RSI already showing negative divergence will have closed back below 40 strongly indicating a test of the Q4 2022 trough at around 119.

Source all charts and data: Saxo Group

Demant broke bullish out of its Symmetrical triangle like pattern last week but have been rejected at the resistance at around 237.80 and the around the 200 daily Moving Average. A close below 218 could add to the current selling pressure for Deman to drop to test support at around 201.

Demant was also rejected at the 200 weekly Moving Average  and it will be a struggle to penetrate it. Demant is likely to be range bound between 175 and 241 for quite some time.

For Demant to resume uptrend at close above 238 is needed. Daily RSI is showing positive sentiment indicating Demant is likely to have another go at the resistance level

Rockwool A/S disappointed on both earnings and outlook yesterday and the share price was severely punished closing 17% down. It bounced off the 200 daily Moving Average and the bounce seems to continue today. If Rockwool can move above 1,823 the short-term uptrend could be resumed.
RSI is in negative territory however, indicating lower levels. Rockwool could very well be stuck in a sideway range between 1,500 and 2,100 for a while.  
 
Weekly chart Rockwool is trading in a wide rising channel but was rejected at the 200 weekly Moving Average. The uptrend remains intact. A close below 1,500 is needed to reverse that. If Rockwool takes out 1,500 the weekly RSI is likely to reverse to negative sentiment.
A close below the rising trendline will indicate Rockwool will be quite likely to play out that bearish scenario that could take the share price close to 1,000.

Chemometic, once a darling on the Exchange is taking a serious beating this morning. The stock has been in a downtrend for some time however, and it seems like a collapse of a bubble. Monthly chart clearly shows the Bubble pattern.
Some support here around the 55 monthly Moving Average  but no strong support until the Consolidation area at around 449-368.

Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.